Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT

Journal of Nuclear Medicine

Volumn 52, Issue 7, 2011, Pages 1068-1072

  Seo, Youngho ^a,b,c   Aparici, Carina Mari ^a,d   Chen, Chien Peter ^a   Hsu, Charles ^a   Kased, Norbert ^a   Schreck, Carole ^a   Costouros, Nick ^a   Hawkins, Randall ^a,b,c   Shinohara, Katsuto ^a   Roach III, Mack ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lymphatic mapping; Prostate cancer; Sentinel node; SPECT CT; Sulfur colloid

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; ISOTOPE LABELING; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MALE; MEMBRANE FILTER; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY; WHOLE BODY SCINTISCANNING;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FILTRATION; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NANOSTRUCTURES; PROSTATIC NEOPLASMS; RADIATION DOSAGE; TECHNETIUM TC 99M SULFUR COLLOID; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960305320     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.085944     Document Type: Article

References (20)

1. Spiotto MT, Hancock SL, King CR. Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. Int J Radiat Oncol Biol Phys. 2007;69:54-61. (Pubitemid 47247505)
2. Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol. 2007;177:916-920. (Pubitemid 46216337)
3. Touijer K, Rabbani F, Otero JR, et al. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%. J Urol. 2007;178:120-124. (Pubitemid 46898466)
4. Briganti A, Karakiewicz PI, Chun FK, et al. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol. 2007;51:1573-1581. (Pubitemid 46634767)
5. Briganti A, Gallina A, Suardi N, et al. A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. BJU Int. 2008;101:556-560. (Pubitemid 351199277)
6. Wagner M, Sokoloff M, Daneshmand S. The role of pelvic lymphadenectomy for prostate cancer: therapeutic? J Urol. 2008;179:408-413.
7. Roach M III, DeSilvio M, Valicenti R, et al. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys. 2006;66:647-653.
8. Ploysongsang SS, Aron BS, Shehata WM. Radiation therapy in prostate cancer: whole pelvis with prostate boost or small field to prostate? Urology. 1992;40:18-26.
9. Ganswindt U, Paulsen F, Corvin S, et al. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys. 2007;67:347-355. (Pubitemid 46108338)
10. Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol. 2007;52:126-132.
11. Alicikus ZA, Yamada Y, Zhang Z. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer. 2011;117:1429-1437.
12. Ganswindt U, Paulsen F, Corvin S. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. BMC Cancer. 2005;5:91.
13. Jimenez IR, Roca M, Vega E, et al. Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nucl Med Commun. 2008;29:166-172. (Pubitemid 350306775)
14. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging. 2009;36:1377-1382.
15. Vermeeren L, Muller SH, Meinhardt W, Valdes Olmos RA. Optimizing the colloid particle concentration for improved preoperative and intraoperative image-guided detection of sentinel nodes in prostate cancer. Eur J Nucl Med Mol Imaging. 2010;37:1328-1334.
16. Ganswindt U, Schilling D, Müller AC, Bares R, Bartenstein P, Belka C. Distribution of prostate sentinel nodes: a SPECT-derived anatomic atlas. Int J Radiat Oncol Biol Phys. 2011;79:1364-1372.
17. Alazraki NP, Eshima D, Eshima LA, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med. 1997;27:55-67. (Pubitemid 27163477)
18. Hung JC, Wiseman GA, Wahner HW, Mullan BP, Taggart TR, Dunn WL. Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J Nucl Med. 1995;36:1895-1901.
19. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027. (Pubitemid 43733519)
20. 99mTc- nanocolloid after intraprostatic injection [in German]. Nuklearmedizin. 2002;41:102-107.